Open AccessAtrophic enteropathy refractory to a gluten-free diet: what should we consider?
Author(s) -
Alicia Martín Lagos Maldonado,
Fátima García-Consuegra Ruiz-Aragón,
Myriam del Carmen Herrera Mercader
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.6361/2019
Subject(s) - medicine , enteropathy , gluten free , refractory (planetary science) , gastroenterology , gluten , pathology , disease , physics , astrobiology
Olmesartan is an angiotensin II receptor antagonist used for the treatment of blood hypertension. Long-term use has been associated with diarrhea and sometimes intestinal involvement may mimic enteropathies such as celiac disease. Clinicians should consider drugs within the differential diagnosis of enteropathies. We report the case of a female who sought medical help for malabsorptive symptoms and was finally diagnosed with olmesartan-associated gastritis and atrophic enteropathy.